» Articles » PMID: 38473707

Changes in the Expression of Proteins Associated with Neurodegeneration in the Brains of Mice After Infection with Influenza A Virus with Wild Type and Truncated NS1

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Mar 13
PMID 38473707
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza type A virus (IAV) infection is a major cause of morbidity and mortality during influenza epidemics. Recently, a specific link between IAV infection and neurodegenerative disease progression has been established. The non-structural NS1 protein of IAV regulates viral replication during infection and antagonizes host antiviral responses, contributing to influenza virulence. In the present study, we have prepared a mouse lung-to-lung adapted to the NS1-truncated virus (NS80ad). Transcriptome analysis of the gene expression in the lungs revealed that infection with wild-type A/WSN/33 (WSN), NS80, and NS80ad viruses resulted in different regulation of genes involved in signaling pathways associated with the cell proliferation, inflammatory response, and development of neurodegenerative diseases. NS1 protein did not influence the genes involved in the RIG-I-like receptor signaling pathway in the brains. Lethal infection with IAVs dysregulated expression of proteins associated with the development of neurodegenerative diseases (CX3CL1/Fractalkine, Coagulation factor III, and CD105/Endoglin, CD54/ICAM-1, insulin-like growth factor-binding protein (IGFBP)-2, IGFBP-5, IGFBP-6, chitinase 3-like 1 (CHI3L1), Myeloperoxidase (MPO), Osteopontin (OPN), cystatin C, and LDL R). Transcription of GATA3 mRNA was decreased, and expression of MPO was inhibited in the brain infected with NS80 and NS80ad viruses. In addition, the truncation of NS1 protein led to reduced expression of IGFBP-2, CHI3L1, MPO, and LDL-R proteins in the brains. Our results indicate that the influenza virus influences the expression of proteins involved in brain function, and this might occur mostly through the NS1 protein. These findings suggest that the abovementioned proteins represent a promising target for the development of potentially effective immunotherapy against neurodegeneration.

Citing Articles

Research progress on the nonstructural protein 1 (NS1) of influenza a virus.

Zhang X, Zhang Y, Wei F Virulence. 2024; 15(1):2359470.

PMID: 38918890 PMC: 11210920. DOI: 10.1080/21505594.2024.2359470.

References
1.
Nacken W, Schreiber A, Masemann D, Ludwig S . The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus. mBio. 2021; 12(5):e0219621. PMC: 8546537. DOI: 10.1128/mBio.02196-21. View

2.
Smeyne R, Noyce A, Byrne M, Savica R, Marras C . Infection and Risk of Parkinson's Disease. J Parkinsons Dis. 2020; 11(1):31-43. PMC: 7990414. DOI: 10.3233/JPD-202279. View

3.
Gao R, Dong L, Dong J, Wen L, Zhang Y, Yu H . A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One. 2010; 5(10):e13315. PMC: 2953511. DOI: 10.1371/journal.pone.0013315. View

4.
Rauskolb S, Andreska T, Fries S, von Collenberg C, Blum R, Monoranu C . Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment. Acta Neuropathol Commun. 2022; 10(1):68. PMC: 9074221. DOI: 10.1186/s40478-022-01352-5. View

5.
Raut S, Hurd J, Blandford G, Heath R, CURETON R . The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus. J Med Microbiol. 1975; 8(1):127-36. DOI: 10.1099/00222615-8-1-127. View